Ransohoff RM - Search Results

1

The expression and function of chemokines involved in CNS inflammation.

Ubogu EE, Cossoy MB, Ransohoff RM. Ubogu EE, et al. Among authors: ransohoff rm. Trends Pharmacol Sci. 2006 Jan;27(1):48-55. doi: 10.1016/j.tips.2005.11.002. Epub 2005 Nov 28. Trends Pharmacol Sci. 2006. PMID: 16310865 Review.

2

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD. Wujek JR, et al. Among authors: ransohoff rm. J Neuropathol Exp Neurol. 2002 Jan;61(1):23-32. doi: 10.1093/jnen/61.1.23. J Neuropathol Exp Neurol. 2002. PMID: 11829341

3

Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.

Matsui M, Weaver J, Proudfoot AE, Wujek JR, Wei T, Richer E, Trapp BD, Rao A, Ransohoff RM. Matsui M, et al. Among authors: ransohoff rm. J Neuroimmunol. 2002 Jul;128(1-2):16-22. doi: 10.1016/s0165-5728(02)00121-2. J Neuroimmunol. 2002. PMID: 12098506

4

Growth factor treatment of demyelinating disease: at last, a leap into the light.

Ransohoff RM, Howe CL, Rodriguez M. Ransohoff RM, et al. Trends Immunol. 2002 Nov;23(11):512-6. doi: 10.1016/s1471-4906(02)02321-9. Trends Immunol. 2002. PMID: 12401395

5

The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).

Mahad DJ, Ransohoff RM. Mahad DJ, et al. Among authors: ransohoff rm. Semin Immunol. 2003 Feb;15(1):23-32. doi: 10.1016/s1044-5323(02)00125-2. Semin Immunol. 2003. PMID: 12495638 Review.

6

Analysis of leukocyte extravasation across the blood-brain barrier: conceptual and technical aspects.

Callahan MK, Ransohoff RM. Callahan MK, et al. Among authors: ransohoff rm. Curr Allergy Asthma Rep. 2004 Jan;4(1):65-73. doi: 10.1007/s11882-004-0046-9. Curr Allergy Asthma Rep. 2004. PMID: 14680625 Review.

7

Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.

Mahad DJ, Trebst C, Kivisäkk P, Staugaitis SM, Tucky B, Wei T, Lucchinetti CF, Lassmann H, Ransohoff RM. Mahad DJ, et al. Among authors: ransohoff rm. J Neuropathol Exp Neurol. 2004 Mar;63(3):262-73. doi: 10.1093/jnen/63.3.262. J Neuropathol Exp Neurol. 2004. PMID: 15055450

8

Expression of CCR7 in multiple sclerosis: implications for CNS immunity.

Kivisäkk P, Mahad DJ, Callahan MK, Sikora K, Trebst C, Tucky B, Wujek J, Ravid R, Staugaitis SM, Lassmann H, Ransohoff RM. Kivisäkk P, et al. Among authors: ransohoff rm. Ann Neurol. 2004 May;55(5):627-38. doi: 10.1002/ana.20049. Ann Neurol. 2004. PMID: 15122702

9

New directions in MS therapeutics: vehicles of hope.

Fox RJ, Ransohoff RM. Fox RJ, et al. Among authors: ransohoff rm. Trends Immunol. 2004 Dec;25(12):632-6. doi: 10.1016/j.it.2004.09.012. Trends Immunol. 2004. PMID: 15530830 Review.

10

Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice.

Huang D, Wujek J, Kidd G, He TT, Cardona A, Sasse ME, Stein EJ, Kish J, Tani M, Charo IF, Proudfoot AE, Rollins BJ, Handel T, Ransohoff RM. Huang D, et al. Among authors: ransohoff rm. FASEB J. 2005 May;19(7):761-72. doi: 10.1096/fj.04-3104com. FASEB J. 2005. PMID: 15857890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters